90/014,599PROCESS FOR PREPARING CYCLOPHOSPHAMIDE, INTERMEDIATES, AND MONOHYDRATE THEREOF10,479,811Closed

Status

Reexamination Certificate Issued

Filed

Dec 17, 2020

Last Updated

Jul 23, 2021

Art Unit

3991

Requester Law Firm

Unknown

Requested By

Third Party

Patent OwnerInferred

Pharmacore Biotech Co. Ltd.

P.O. Law Firm

WPAT, P.C.

Sector (CPC)

CChemistry & Materials
C07Organic Chemistry
C07FAcyclic Organometallic

USPC

556Organic Compounds

Reexam History (30 events)

Jul 24, 2021CCRDYApplication ready for PDX access by participating foreign offices
Jul 23, 2021REEXInput Issue Number and Issue Date for Reexamination
Jul 7, 2021RXPUBSReexam Forwarded to Office of Publications
Jun 29, 2021MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Jun 9, 2021RXLITSRReexam Litigation Search Conducted
Jun 4, 2021RXC/SRCertificate of Service
Jun 4, 2021RXA...Response after Non-Final Action
Apr 6, 2021MR.NFRX - Mail Reexam Non-Final Action
Mar 10, 2021RXFWDXDate Forwarded to Examiner
Jan 8, 2021MREXORX - Mail Ex Parte Request for Reexamination Granted
Jan 5, 2021NRX.Notice of Reexam Published in Official Gazette
Dec 22, 2020ROIPEApplication Return TO OIPE
Dec 17, 2020RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Dec 17, 2020RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Dec 17, 2020RXDOCKReexam Assigned to Examiner for Determination
Dec 17, 2020RXC/SRCertificate of Service
Nov 30, 2020MRIFDRX - Mail Incomplete Ex Parte Reexam Request (Filing Date vacated)
Nov 12, 2020IDSCInformation Disclosure Statement considered
Nov 10, 2020RXTTLRPTTitle Report
Nov 10, 2020RXLITSRReexam Litigation Search Conducted
Nov 10, 2020DOCKCase Docketed to Examiner in GAU
Nov 9, 2020RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Nov 9, 2020RXNREQFDNotice of reexamination request filing date
Nov 9, 2020RXNREQAUNotice of assignment of reexamination request
Nov 9, 2020FTFSFITF set to YES - revise initial setting
Nov 5, 2020SMALApplicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27
Oct 30, 2020WIDSInformation Disclosure Statement (IDS) Filed
Oct 30, 2020RXOSUBReceipt of Original Ex Parte Reexam Request
Oct 30, 2020RXO_40.RReceipt of Orig. Ex Parte Request by Third Party Less Than 40 Pages - Rule 1.20(c )(1)
Oct 30, 2020BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
Nov 19, 2019
3.5-yr
May 19, 2023
7.5-yr
May 19, 2027
11.5-yr
May 19, 2031
Expiry
Dec 5, 2038

Entity Status

Small Entity

Expires

Dec 5, 2038 (12.7 yr remaining)

Other

USPTO Event: Expire PatentUSPTO Event: Maintenance Fee Reminder Mailed

Assignments

Jun 2018Jul 2018Aug 2018Sep 2018Oct 2018Nov 2018Dec 2018FiledHSING YU CHANGCHIA-YU LINVALLAPA SOONGWEI-HONG TSENGKO HUA YUPHARMACORE BIOTECH CO., LTD.
AssignmentReel/Frame: 047720/0015Recorded: Dec 5, 2018

From

HSING YU CHANGInventor
May 28, 2018
CHIA-YU LINInventor
May 28, 2018
VALLAPA SOONGInventor
May 28, 2018
WEI-HONG TSENGInventor
May 28, 2018
KO HUA YUInventor
May 28, 2018

To

PHARMACORE BIOTECH CO., LTD.